| Filed On | Filing |
|---|---|
| 10 Mar 2022 | AMENDMENT NO. 2 TO SCHEDULE 13G |
| 07 Mar 2022 | FORM 15-12B |
| 23 Feb 2022 | 8-K: Completion of Acquisition or Disposition of Assets; Triggering Events That Accelerate a Financial Obligation +5 more |
| 23 Feb 2022 |
Form 4: Sundaram Bharat, Director
Returned 16,420 shares to the issuer |
| 23 Feb 2022 |
Form 4: Paulus Ronald A, Director
Returned 16,194 shares to the issuer |
| 23 Feb 2022 |
Form 4: O'keefe Sharon, Director
Gave 1,900 shares as a gift · Returned 42,166 shares to the issuer |
| 23 Feb 2022 |
Form 4: McMullen John N, Director
Returned 25,329 shares to the issuer |
| 23 Feb 2022 |
Form 4: Lang Brent D., Director
Received 254,184 shares as a grant or award · Returned 699,881 shares to the issuer · Disposed of 3 Stock Option (right to buy) (Disposition to Issuer) |
| 23 Feb 2022 |
Form 4: King Alexa, Director
Returned 42,108 shares to the issuer |
| 23 Feb 2022 |
Form 4: Johnson Paul T, EVP Sales and Services
Received 87,649 shares as a grant or award · Returned 218,865 shares to the issuer · Disposed of 48,552 Stock Option (right to buy) (Disposition to Issuer) |
| 23 Feb 2022 |
Form 4: Janzen Howard E, Director
Returned 45,066 shares to the issuer |
| 23 Feb 2022 |
Form 4: Iskow Julie, Director
Returned 16,420 shares to the issuer |
| 23 Feb 2022 |
Form 4: Duffy Mary Bridget, Chief Medical Officer
Received 54,266 shares as a grant or award · Returned 117,723 shares to the issuer |
| 23 Feb 2022 |
Form 4: Carlen Douglas Alan, General Counsel
Received 54,266 shares as a grant or award · Returned 133,957 shares to the issuer |
| 23 Feb 2022 |
Form 4: Burkland Michael, Director
Returned 44,937 shares to the issuer |
| 23 Feb 2022 |
Form 4: Anheier Steve, Chief Financial Officer
Received 40,874 shares as a grant or award · Returned 74,116 shares to the issuer |
| 23 Feb 2022 | S-8 POS |
| 23 Feb 2022 | S-8 POS |
| 23 Feb 2022 | S-8 POS |
| 23 Feb 2022 | S-8 POS |
Loading...